Cargando…

Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease

As butyrylcholinesterase (BChE) plays a role in the progression of symptoms and pathophysiology of Alzheimer’s disease (AD), selective inhibition of BChE over acetylcholinesterase (AChE) can represent a promising pathway in treating AD. The carbamate group was chosen as a pharmacophore because the c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matošević, Ana, Knežević, Anamarija, Zandona, Antonio, Maraković, Nikola, Kovarik, Zrinka, Bosak, Anita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609992/ https://www.ncbi.nlm.nih.gov/pubmed/36297332 http://dx.doi.org/10.3390/ph15101220

Ejemplares similares

Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold
por: Bosak, Anita, et al.
Publicado: (2018)

Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity
por: Bosak, Anita, et al.
Publicado: (2017)

New Cinchona Oximes Evaluated as Reactivators of Acetylcholinesterase and Butyrylcholinesterase Inhibited by Organophosphorus Compounds
por: Katalinić, Maja, et al.
Publicado: (2017)

Assessment of four organophosphorus pesticides as inhibitors of human acetylcholinesterase and butyrylcholinesterase
por: Čadež, Tena, et al.
Publicado: (2021)

4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer’s Disease
por: Komatović, Katarina, et al.
Publicado: (2022)

Potential of Vitamin B6 Dioxime Analogues to Act as Cholinesterase Ligands
por: Gašo Sokač, Dajana, et al.
Publicado: (2022)

Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer’s Diseases
por: Guo, Yan, et al.
Publicado: (2020)

Vitamin B3-Based Biologically Active Compounds as Inhibitors of Human Cholinesterases
por: Zandona, Antonio, et al.
Publicado: (2020)

Novel 1,2,4-oxadiazole derivatives as selective butyrylcholinesterase inhibitors: Design, synthesis and biological evaluation
por: Nazari, Maryam, et al.
Publicado: (2021)

Synthesis, Biological Evaluation and Machine Learning Prediction Model for Fluorinated Cinchona Alkaloid-Based Derivatives as Cholinesterase Inhibitors
por: Ramić, Alma, et al.
Publicado: (2022)

Palladium-catalyzed formation of oxazolidinones from biscarbamates: a mechanistic study
por: Kilbas, Benan, et al.
Publicado: (2011)

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease
por: Kumar, Amit, et al.
Publicado: (2018)

Synthesis and biological evaluation of lycorine derivatives as dual inhibitors of human acetylcholinesterase and butyrylcholinesterase
por: Wang, Yue-Hu, et al.
Publicado: (2012)

New Thienobenzo/Naphtho-Triazoles as Butyrylcholinesterase Inhibitors: Design, Synthesis and Computational Study
por: Mlakić, Milena, et al.
Publicado: (2023)

Synthesis and biological evaluation of aminomethyl and alkoxymethyl derivatives as carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase inhibitors
por: Gulçin, İlhami, et al.
Publicado: (2017)

Serotonin 5-HT(6) Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer’s Disease
por: Więckowski, Krzysztof, et al.
Publicado: (2022)

Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase
por: Wang, Dong-mei, et al.
Publicado: (2017)

Carbamate Group as Structural Motif in Drugs: A Review of Carbamate Derivatives used as Therapeutic Agents
por: Matošević, Ana, et al.
Publicado: (2020)

Quinuclidine-Based Carbamates as Potential CNS Active Compounds
por: Matošević, Ana, et al.
Publicado: (2021)

Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates
por: Bosak, Anita, et al.
Publicado: (2020)

Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer’s Disease
por: Jones, Mike, et al.
Publicado: (2016)

Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery
por: Wang, Yu-Qiang, et al.
Publicado: (2012)

Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies
por: Mamun, Abdullah Al, et al.
Publicado: (2021)

Design, Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Study of Benzimidazole-Based Oxazole Analogues: A Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors
por: Hussain, Rafaqat, et al.
Publicado: (2023)

Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease
por: Makhaeva, Galina F., et al.
Publicado: (2015)

Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
por: Pohanka, Miroslav
Publicado: (2014)

Biscarbamate cross-linked low molecular weight Polyethylenimine polycation as an efficient intra-cellular delivery cargo for cancer therapy
por: Ge, Xuemei, et al.
Publicado: (2014)

Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
por: Gentzsch, Christian, et al.
Publicado: (2021)

Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent
por: Miao, Shuang, et al.
Publicado: (2022)

New anthrarobin acyl derivatives as butyrylcholinesterase inhibitors: synthesis, in vitro and in silico studies
por: Lateef, Mehreen, et al.
Publicado: (2017)

Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes
por: Pajk, Stane, et al.
Publicado: (2020)

Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations
por: Zhou, You, et al.
Publicado: (2019)

Development of an in-vivo active reversible butyrylcholinesterase inhibitor
por: Košak, Urban, et al.
Publicado: (2016)

Molecular interaction of inhibitors with human brain butyrylcholinesterase
por: Shakil, Shazi
Publicado: (2021)

Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors
por: Soyer, Zeynep, et al.
Publicado: (2016)

Novel Inhibitors of Acetyl- and Butyrylcholinesterase Derived from Benzohydrazides: Synthesis, Evaluation and Docking Study
por: Houngbedji, Neto-Honorius, et al.
Publicado: (2023)

Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer's disease
por: dos Santos, Gustavo Alves Andrade, et al.
Publicado: (2011)

Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer’s Activity Profile
por: Makhaeva, Galina F., et al.
Publicado: (2022)

Triterpene-Based Carboxamides Act as Good Inhibitors of Butyrylcholinesterase
por: Loesche, Anne, et al.
Publicado: (2019)

Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor
por: Zakošek Pipan, Maja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vq45be7ejbl9rgnj0tb9k9981q